List of Tables
Table 1. Cancer Early Detection and Diagnosis Market Trends
Table 2. Cancer Early Detection and Diagnosis Market Drivers & Opportunity
Table 3. Cancer Early Detection and Diagnosis Market Challenges
Table 4. Cancer Early Detection and Diagnosis Market Restraints
Table 5. Global Cancer Early Detection and Diagnosis Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancer Early Detection and Diagnosis Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cancer Early Detection and Diagnosis Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cancer Early Detection and Diagnosis Product Type
Table 9. Key Companies Time to Begin Mass Production of Cancer Early Detection and Diagnosis
Table 10. Global Cancer Early Detection and Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Early Detection and Diagnosis as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cancer Early Detection and Diagnosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cancer Early Detection and Diagnosis Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cancer Early Detection and Diagnosis Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cancer Early Detection and Diagnosis Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cancer Early Detection and Diagnosis Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cancer Early Detection and Diagnosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cancer Early Detection and Diagnosis Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cancer Early Detection and Diagnosis Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cancer Early Detection and Diagnosis Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cancer Early Detection and Diagnosis Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cancer Early Detection and Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cancer Early Detection and Diagnosis Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cancer Early Detection and Diagnosis Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cancer Early Detection and Diagnosis Sales Value by Region (2019-2024) & (%)
Table 27. Global Cancer Early Detection and Diagnosis Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cancer Early Detection and Diagnosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cancer Early Detection and Diagnosis Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cancer Early Detection and Diagnosis Sales Value, (2025-2030) & (US$ Million)
Table 31. Exact Sciences Basic Information List
Table 32. Exact Sciences Description and Business Overview
Table 33. Exact Sciences Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Exact Sciences (2019-2024)
Table 35. Exact Sciences Recent Developments
Table 36. Grail Basic Information List
Table 37. Grail Description and Business Overview
Table 38. Grail Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Grail (2019-2024)
Table 40. Grail Recent Developments
Table 41. Genetron Health Basic Information List
Table 42. Genetron Health Description and Business Overview
Table 43. Genetron Health Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Genetron Health (2019-2024)
Table 45. Genetron Health Recent Developments
Table 46. New Horizon Health Basic Information List
Table 47. New Horizon Health Description and Business Overview
Table 48. New Horizon Health Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of New Horizon Health (2019-2024)
Table 50. New Horizon Health Recent Developments
Table 51. Burning Rock Basic Information List
Table 52. Burning Rock Description and Business Overview
Table 53. Burning Rock Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Burning Rock (2019-2024)
Table 55. Burning Rock Recent Developments
Table 56. Berry Oncology Basic Information List
Table 57. Berry Oncology Description and Business Overview
Table 58. Berry Oncology Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Berry Oncology (2019-2024)
Table 60. Berry Oncology Recent Developments
Table 61. Shanghai Kunyuan Biotechnology Basic Information List
Table 62. Shanghai Kunyuan Biotechnology Description and Business Overview
Table 63. Shanghai Kunyuan Biotechnology Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Shanghai Kunyuan Biotechnology (2019-2024)
Table 65. Shanghai Kunyuan Biotechnology Recent Developments
Table 66. Oncognostic Basic Information List
Table 67. Oncognostic Description and Business Overview
Table 68. Oncognostic Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Oncognostic (2019-2024)
Table 70. Oncognostic Recent Developments
Table 71. Epigenomics Basic Information List
Table 72. Epigenomics Description and Business Overview
Table 73. Epigenomics Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Epigenomics (2019-2024)
Table 75. Epigenomics Recent Developments
Table 76. Abbott Basic Information List
Table 77. Abbott Description and Business Overview
Table 78. Abbott Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Abbott (2019-2024)
Table 80. Abbott Recent Developments
Table 81. Qiagen Basic Information List
Table 82. Qiagen Description and Business Overview
Table 83. Qiagen Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of Qiagen (2019-2024)
Table 85. Qiagen Recent Developments
Table 86. iStat Biomedical Basic Information List
Table 87. iStat Biomedical Description and Business Overview
Table 88. iStat Biomedical Cancer Early Detection and Diagnosis Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cancer Early Detection and Diagnosis Business of iStat Biomedical (2019-2024)
Table 90. iStat Biomedical Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Cancer Early Detection and Diagnosis Downstream Customers
Table 94. Cancer Early Detection and Diagnosis Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cancer Early Detection and Diagnosis Product Picture
Figure 2. Global Cancer Early Detection and Diagnosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancer Early Detection and Diagnosis Sales Value (2019-2030) & (US$ Million)
Figure 4. Cancer Early Detection and Diagnosis Report Years Considered
Figure 5. Global Cancer Early Detection and Diagnosis Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Early Detection and Diagnosis Revenue in 2023
Figure 7. Cancer Early Detection and Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Colorectal Cancer Picture
Figure 9. Liver Cancer Picture
Figure 10. Lung Cancer Picture
Figure 11. Other Picture
Figure 12. Global Cancer Early Detection and Diagnosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Cancer Early Detection and Diagnosis Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospital
Figure 15. Product Picture of Medical Center
Figure 16. Product Picture of Other
Figure 17. Global Cancer Early Detection and Diagnosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Cancer Early Detection and Diagnosis Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Cancer Early Detection and Diagnosis Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Cancer Early Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Cancer Early Detection and Diagnosis Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Cancer Early Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Cancer Early Detection and Diagnosis Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Cancer Early Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Cancer Early Detection and Diagnosis Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Cancer Early Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Cancer Early Detection and Diagnosis Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Cancer Early Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Cancer Early Detection and Diagnosis Sales Value (%), (2019-2030)
Figure 30. United States Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 36. China Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 38. China Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 48. India Cancer Early Detection and Diagnosis Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Cancer Early Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
Figure 50. India Cancer Early Detection and Diagnosis Sales Value by Application (%), 2023 VS 2030
Figure 51. Cancer Early Detection and Diagnosis Industrial Chain
Figure 52. Cancer Early Detection and Diagnosis Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
